
HVAX Technologies Limited
listed
₹1.31LMin. investment
About HVAX Technologies Limited
Issue size
₹33.53Cr
IPO type
SME
Price range
₹435 – ₹458
Lot size
300 shares
Price range₹435 – ₹458
IPO type
SME
Lot size300 shares
Issue size₹33.53Cr
Checklist
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
A bout HVAX Technologies Limited
Founded in 2010, HVAX Technologies Limited has significantly transformed from its initial role as an HVAC project contractor to a leading provider of comprehensive turnkey solutions for controlled environment infrastructure and cleanrooms. The company specializes in the engineering, procurement, and execution of projects tailored primarily for the pharmaceutical sector, while also serving chemical companies, hospitals, healthcare providers, and FMCG firms. With a commitment to quality and innovation, HVAX has become a trusted partner for clients seeking reliable solutions in cleanroom technology and controlled environments.
HVAX Technologies excels in delivering end-to-end solutions that encompass the entire project lifecycle, from design and engineering to procurement, installation, testing, commissioning, and operational support. The company’s extensive portfolio includes a wide range of third-party manufactured products, such as cleanroom wall and ceiling panels, flooring systems, air handling units, and Building Management Systems (BMS). By providing comprehensive service offerings, HVAX ensures that its clients receive customized solutions that meet their specific requirements, reinforcing its reputation for excellence in project execution.
With a track record of completing around 200 projects across India and 15 countries—including Algeria, UAE, and South Africa—HVAX Technologies has established itself as a key player in the global market for controlled environments.
At the core of HVAX Technologies’ operations is a dedicated team of 125 permanent and 21 temporary employees, complemented by skilled contract labor for project execution. The company prioritizes a client-centric approach, engaging directly with customers and collaborating with subcontractors to ensure timely and successful project outcomes. HVAX’s emphasis on high-quality, safe, and innovative solutions reflects its commitment to meeting the diverse needs of its clients in the pharmaceutical, healthcare, and biotech sectors, reinforcing its position as a leader in controlled environment solutions.
HVAX Technologies Limited prepares for its Initial Public Offering (IPO), the proceeds from the Fresh Issue will be allocated towards critical objectives
- Funding the working capital requirements.
- General Corporate Purpose.
Frequently asked questions
How to invest in the IPO?
Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.
What is the issue size of HVAX Technologies Limited ?
The issue size of the HVAX Technologies Limited is 33.53 Cr.
What is 'pre-apply' for HVAX Technologies Limited ?
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
Which exchanges will HVAX Technologies Limited shares list on?
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Timeline
- Bidding starts27 Sep 2024
- Bidding ends1 Oct 2024
- Allotment finalisation29 Sep 2024
- Release of funds4 Oct 2024
- Demat transfer3 Oct 2024
- Listing7 Oct 2024